Research has shown that GLP-1 receptor agonists may reduce inflammation in the body
Is this temporary
However, many patients worry about side effects like nausea, vomiting, and gastrointestinal changesand whether these problems persist long-term
In the CNS, GLP-1Rs are expressed by neurons in the hippocampus, which is known to be a cognition-related brain region, and have been observed in neocortical pyramidal neurons (Hamilton and Holscher, 2009)
Preclinical studies have shown benefit for gastric ulcers, inflammatory bowel conditions, and intestinal anastomoses
While retatrutide is still an investigational drug, the latest weight loss science suggests it could be a game-changer for those dealing with binge eating thoughts and emotional eating